{"id":1547,"date":"2023-02-23T17:38:35","date_gmt":"2023-02-23T17:38:35","guid":{"rendered":"https:\/\/www.americanconference.com\/biosimilars\/?page_id=1547"},"modified":"2026-05-22T16:13:11","modified_gmt":"2026-05-22T16:13:11","slug":"overview","status":"publish","type":"page","link":"https:\/\/www.americanconference.com\/biosimilars\/","title":{"rendered":"Overview"},"content":{"rendered":"<!-- #2 NEWS START -->\r\n<style>\r\n#news-component { background-color: #121212; margin-top: 0px !important; padding: 72px 0px 96px; }\r\n#news-component .news-cell { border-left: 1px solid rgba(255, 255, 255, 0.1); padding: 15px 0px 0px 24px; }\r\n#news-component h3 { margin-bottom: 34px !important; color: #fff !important; }\r\n#news-component h5 { margin-bottom: 12px !important; color: #fff !important; font-size: 16px; line-height: 24px !important; }\r\n#news-component p { margin-bottom: 12px !important; color: #fff !important; }\r\n#news-component a { color: #fff !important; outline: none; text-transform: uppercase; font-weight: bold; font-size: 14px; letter-spacing: 0.7px; }\r\n@media screen and (max-width: 1535px) {\r\n}\r\n@media screen and (max-width: 1279px) {\r\n}\r\n@media screen and (max-width: 1023px) {\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #news-component .news-cell img { display: none !important; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #news-component .news-cell img { display: none !important; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"news-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n  <div class=\"content-wrap\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-2 col-xl-3\">\r\n      <h3>Latest News &#038; Updates<\/h3>\r\n    <\/div>\r\n    <div class=\"col-xxxs-6 col-md-6 col-lg-5 col-xl-4\">\r\n      <div class=\"news-cell\">\r\n        <h5>View the Agenda<\/h5>\r\n        <p>See the sessions shaping this year\u2019s discussion.<\/p>\r\n        <a href=\".\/agenda\/\">View Agenda<\/a>\r\n      <\/div>\r\n    <\/div>\r\n    <div class=\"col-xxxs-6 col-md-6 col-lg-5 col-xl-4\">\r\n      <div class=\"news-cell\">\r\n        <h5>Who&#8217;s Attending?<\/h5>\r\n        <p>See the companies already confirmed to attend.<\/p>\r\n        <a href=\".\/attending-organizations\/\">VIEW ATTENDEES<\/a>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #2 NEWS END -->\r\n\r\n\r\n<!-- #3 OPENING START -->\r\n<style>\r\n#intro-component { margin-top: 144px; margin-bottom: 168px; }\r\n#intro-component h2 { margin-bottom: 32px !important; }\r\n#intro-component .copy-wrap { max-width: 636px; }\r\n#intro-component .img-wrap img { border-radius: 2px; }\r\n#intro-component a.mainlink { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1279px) {\r\n  #intro-component { margin-top: 72px; margin-bottom: 96px; }\r\n  #intro-component .copy-wrap { max-width: initial; margin-bottom: 29px; }\r\n  #intro-component .img-wrap img { width: 100%; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"intro-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-6 col-xl-6\">\r\n      <div class=\"copy-wrap\">\r\n        <h2>Stay Ahead in a Defining Year for Biosimilars and Biologics<\/h2>\r\n        <p>Join ACI\u2019s Biosimilars &#038; Innovator Biologics Summit in New York and connect with industry leaders navigating the biggest shifts in IP, regulation, and market access.<\/p>\r\n        <p>Get practical insights on:<\/p>\r\n         \t<ul>\r\n                <li>Evolving IP and litigation strategies<\/li>\r\n        \t<li>FDA and regulatory developments<\/li>\r\n         \t<li>Market access and pricing pressures<\/li>\r\n         \t<li>Global competition shaping the future of biologics<\/li><\/ul>\r\n        <p>2026 will define the next phase of innovation and patient access. Join the \u201cwho\u2019s who\u201d of the biosimilars and innovator biologics community this June in New York and make sure you\u2019re part of the conversation.<\/p>\r\n        <a href=\".\/agenda\/\" class=\"mainlink\">View Agenda<\/a>\r\n      <\/div>\r\n    <\/div>\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-6 col-xl-6\">\r\n      <div class=\"img-wrap\">\r\n        <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg\" alt=\"\" width=\"672\" height=\"480\" \/>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #3 OPENING END -->\r\n\r\n\r\n\r\n<!-- UPPER START -->\r\n<style>\r\n#upper-component { background-color: #F5F5F5; padding: 48px 0px 168px; }\r\n@media screen and (max-width: 1279px) {\r\n  #upper-component { padding: 0px 0px 120px; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #upper-component { padding: 36px 0px 96px; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"upper-component\">\r\n<div class=\"container\">\r\n\r\n\r\n<!-- #4 SPEAKERS START -->\r\n<style>\r\n#featured-speakers-component { padding: 96px 0px 0px; }\r\n#featured-speakers-component h2 { margin-bottom: 37px !important; }\r\n#featured-speakers-component .speaker-sections-wrap { margin-bottom: -79px; }\r\n#featured-speakers-component .speaker-section { margin-bottom: 79px; }\r\n#featured-speakers-component .speaker-wrap { display: flex; margin-left: -24px; margin-right: -24px; }\r\n#featured-speakers-component .speaker-wrap .speaker { width: 192px; margin-left: 24px; margin-right: 24px; text-align: center; }\r\n#featured-speakers-component .speaker-wrap .speaker img { border-radius: 36px; margin: 0 auto 19px; }\r\n#featured-speakers-component .speaker-wrap .speaker .name { font-weight: bold; margin-bottom: 3px; line-height: 24px; }\r\n#featured-speakers-component .speaker-wrap .speaker .details { font-size: 14px; line-height: 20px; }\r\n#featured-speakers-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1279px) {\r\n  #featured-speakers-component { padding: 96px 0px 0px; }\r\n  #featured-speakers-component .speaker-wrap { flex-direction: row; flex-wrap: wrap; align-items: center; margin-left: -16px; margin-right: -16px; }\r\n  #featured-speakers-component .speaker-wrap .speaker { width: 128px; margin-left: 16px; margin-right: 16px; }\r\n  #featured-speakers-component .speaker-wrap .speaker img { border-radius: 36px; margin: 0 auto 18px; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #featured-speakers-component .speaker-wrap { flex-direction: row; flex-wrap: wrap; align-items: center; margin-left: 0; margin-right: 0; }\r\n  #featured-speakers-component .speaker-wrap .speaker { width: 156px; margin-bottom: 48px; margin-left: 12px; margin-right: 12px; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #featured-speakers-component h6, #featured-speakers-component h2 { text-align: left; }\r\n  #featured-speakers-component .speaker-wrap { flex-direction: row; flex-wrap: wrap; align-items: center; margin-left: -12px; margin-right: -12px; }\r\n  #featured-speakers-component .speaker-wrap .speaker { width: 156px; margin-bottom: 48px; margin-left: 12px; margin-right: 12px; }\r\n  #featured-speakers-component .speaker-wrap .speaker img { border-radius: 2px; }\r\n  #featured-speakers-component .speaker-wrap div.speaker:last-child { margin-bottom: 0; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"featured-speakers-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <div class=\"speaker-sections-wrap\">\r\n        <div class=\"speaker-section\">\r\n\r\n          <h2>Conference <span style=\"white-space:nowrap;\">Co-Chairs<\/span><\/h2>\r\n          <div class=\"speaker-wrap\">\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2026\/02\/james-t-evans.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">James Evans<\/p>\r\n              <p class=\"details\"><em>Senior Director, Assistant General Counsel, Global IP Litigation<\/em><br><span style=\"font-weight:500;\">Regeneron Pharmaceuticals, Inc.<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2021\/04\/katie-nolan-stevaux.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Katie Nolan-Stevaux<\/p>\r\n              <p class=\"details\"><em>Head of General Litigation, Associate General Counsel<\/em><br><span style=\"font-weight:500;\">Genentech<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2022\/04\/jason-murata.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Jason Murata<\/p>\r\n              <p class=\"details\"><em>Vice President, Intellectual Property<\/em><br><span style=\"font-weight:500;\">Alvotech<\/span><\/p>\r\n            <\/div>\r\n          <\/div>\r\n\r\n          <hr>\r\n\r\n          <h2>Government Speakers<\/h2>\r\n          <div class=\"speaker-wrap\">\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2023\/03\/mustafa-unlu-2.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Mustafa \u00dcnl\u00fc<\/p>\r\n              <p class=\"details\"><em>Policy Staff Director, Office of Therapeutic Biologics and Biosimilars<\/em><br><span style=\"font-weight:500;\">U.S. Food and Drug Administration<\/span><\/p>\r\n            <\/div>\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2023\/03\/anu-sawkar-1.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Anu Sawkar<\/p>\r\n              <p class=\"details\"><em>Special Counsel for Intellectual Property<\/em><br><span style=\"font-weight:500;\">Federal Trade Commission<\/span><\/p>\r\n            <\/div>\r\n<!--\r\n            <div class=\"speaker\">\r\n              <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/2268\/2024\/12\/Reference-Placeholder.png\" alt=\"Speaker Headshot\" width=\"144\" height=\"144\" \/>\r\n              <p class=\"name\">Name<\/p>\r\n              <p class=\"details\"><em>Title<\/em><br><span style=\"font-weight:500;\">Company<\/span><\/p>\r\n            <\/div>\r\n-->\r\n          <\/div>\r\n          <hr>\r\n\r\n      <a href=\".\/speakers\/\">View All Speakers<\/a>\r\n\r\n        <\/div>\r\n      <\/div>\r\n\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #4 SPEAKERS END -->\r\n\r\n\r\n<!-- #5 ADVISORY BOARD START -->\r\n<style>\r\n#advisory-board-component { padding: 96px 0px 0px; }\r\n#advisory-board-component h2 { margin-bottom: 44px !important; }\r\n#advisory-board-component .copy-wrap { max-width: 636px; margin-top:36px; }\r\n#advisory-board-component .img-wrap img { border-radius: 2px; }\r\n#advisory-board-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1279px) {\r\n  #advisory-board-component .copy-wrap { max-width: initial; margin-bottom: 29px; }\r\n  #advisory-board-component .img-wrap img { width: 100%; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"advisory-board-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-6 col-xl-6\">\r\n      <div class=\"copy-wrap vertical-spacer-half\">\r\n        <h2>Advisory Board<\/h2>\r\n        <p>ACI&#8217;s Biosimilars &#038; Innovator Biologics Advisory Board ensures our programs deliver cutting-edge insights with a world-class faculty. Composed of senior IP, market access, regulatory, and policy leaders from both biosimilar and innovator biologics companies, the board provides strategic guidance on litigation, competition, and evolving market dynamics. Balancing perspectives across the industry, this inner circle helps shape critical discussions on innovation, access, and the future of biologics.<\/p>\r\n      <\/div>\r\n      <a href=\".\/advisory-board\/\"><strong style=\"text-decoration:underline;\">View Advisory Board<\/strong><\/a>\r\n    <\/div>\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-6 col-xl-6\">\r\n      <div class=\"img-wrap\">\r\n        <img loading=\"lazy\" decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/2011\/2025\/02\/658L25-BOS-Advisory-Board.jpg\" alt=\"\" width=\"576\" height=\"384\" \/>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #5 ADVISORY BOARD END -->\r\n\r\n\r\n<!-- #6 TOPICS START -->\r\n<style>\r\n#topics-component { padding: 96px 0px 0px; }\r\n#topics-component .bullets-wrap { display: flex; flex-wrap: wrap; margin: 0 -24px -72px; }\r\n#topics-component .bullets-wrap .bullet { width: 312px; border-left: 1px solid rgba(0, 0, 0, 0.1); padding-left: 24px; margin: 0 24px 72px; }\r\n#topics-component .bullet h4 { font-weight: normal; }\r\n#topics-component .bullets-wrap .bullet img { margin-bottom: 0px; }\r\n#topics-component .bullets-wrap .bullet .cls-1 { background-color: #f5f5f5; margin-bottom: 0px; }\r\n#topics-component .bullets-wrap .bullet .cls-1 path { fill:#525252; stroke:#525252; stroke-width:0px; }\r\n#topics-component a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (max-width: 1535px) {\r\n  #topics-component .bullets-wrap { margin: 0 -20px -60px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 20px 60px; }\r\n}\r\n@media screen and (max-width: 1279px) {\r\n  #topics-component .bullets-wrap { margin: 0 -16px -48px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 16px 48px; }\r\n}\r\n@media screen and (max-width: 1023px) {\r\n  #topics-component .bullets-wrap { margin: 0 -12px -36px; }\r\n  #topics-component .bullets-wrap .bullet { margin: 0 12px 36px; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #topics-component { margin-bottom: 127px; }\r\n  #topics-component h2 { text-align: center; }\r\n  #topics-component .bullets-wrap { flex-direction: column; align-items: center; margin-left: 0; margin-right: 0; }\r\n  #topics-component .bullets-wrap .bullet { width: fit-content; padding-left: 0; margin-left: 0; margin-right: 0; border-left: none; text-align: center; }\r\n  #topics-component .bullets-wrap .bullet img { margin-left: auto; margin-right: auto; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"topics-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <h2>Core Topics Shaping the Conversation<\/h2>\r\n      <div class=\"bullets-wrap vertical-spacer-quarter\">\r\n\r\n        <div class=\"bullet\">\r\n         <p>Skinny Labeling and Induced-Infringement may reshape litigation strategy and marketing practices across the industry<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n          <p>The parameters of the Safe Harbor Defense to Patent Infringement are evolving<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n          <p>The price control provisions of the IRA continue to influence innovator biologic and biosimilar development<\/p>\r\n        <\/div>\r\n\r\n        <div class=\"bullet\">\r\n          <p>Artificial Intelligence and IP Strategies can alter product development and litigation planning<\/p>\r\n        <\/div>\r\n\r\n      <\/div>\r\n      <a href=\".\/agenda\/\"><strong style=\"text-decoration:underline;\">View Agenda<\/strong><\/a>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #6 TOPICS END -->\r\n\r\n\r\n<!-- UPPER END -->\r\n<\/div>\r\n<\/div>\r\n\r\n\r\n\r\n<!-- #11 ACCREDITATION START -->\r\n<style>\r\n#accreditation-component { background-image: url(https:\/\/www.canadianinstitute.com\/\/wp-content\/uploads\/sites\/2162\/2024\/11\/accreditation-c-bg.png); background-color: #F5F5F5; background-repeat: no-repeat; height: 528px; }\r\n#accreditation-component .copy-wrap { height: 528px; display: flex; align-items: center; justify-content: center; }\r\n#accreditation-component .copy-wrap .copy { max-width: 648px; margin-left: 480px; }\r\n#accreditation-component .copy-wrap .copy h2 { margin-bottom: 29px !important; }\r\n#accreditation-component .copy-wrap .copy a { font-size: 14px; letter-spacing: 0.7px; font-weight: bold; text-transform: uppercase; text-decoration: underline; outline: none; color: #242424; }\r\n@media screen and (min-width: 2200px) {\r\n  #accreditation-component .copy-wrap .copy { margin-left: 180px; }\r\n}\r\n@media screen and (max-width: 1800px) {\r\n  #accreditation-component .copy-wrap .copy { margin-left: 760px; }\r\n}\r\n@media screen and (max-width: 1279px) {\r\n  #accreditation-component { background-image: none; height: initial; padding-bottom: 176px; }\r\n  #accreditation-component .copy-wrap { justify-content: flex-start; align-items: flex-start; height: initial; }\r\n  #accreditation-component .copy-wrap .copy { max-width: initial; margin-left: 0; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"accreditation-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <div class=\"copy-wrap\">\r\n        <div class=\"copy\">\r\n          <h2>Earn CLE\/Ethics Credits<\/h2>\r\n          <p>Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.<\/p>\r\n          <a href=\"https:\/\/www.americanconference.com\/biosimilars\/earn-cle-ethics-credits\/\">Learn more<\/a>\r\n        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #11 ACCREDITATION END -->\r\n\r\n\r\n<!-- FOLD START -->\r\n<style>\r\n#fold-component { background-color: #242424; padding: 48px 0px 0px; }\r\n<\/style>\r\n<div class=\"row\" id=\"fold-component\">\r\n<div class=\"container\">\r\n\r\n\r\n<!-- #14 ARTICLE START -->\r\n<style>\r\n#article-component { background-color: #242424; padding: 96px 0px 0px; }\r\n#article-component .content-wrap { display: flex; background-color: #F5F5F5; border-radius: 2px; overflow: hidden; }\r\n#article-component .content-wrap .copy-wrap { display: flex; flex-direction: column; align-items: center; justify-content: center; padding: 132px; text-align: center; }\r\n#article-component .content-wrap .copy-wrap img { margin-bottom: 33px; }\r\n#article-component .content-wrap .copy-wrap h3 { margin-bottom: 29px !important; }\r\n#article-component .content-wrap .copy-wrap a { color: #242424; outline: none; text-transform: uppercase; font-weight: bold; font-size: 14px; letter-spacing: 0.7px; }\r\n@media screen and (max-width: 1535px) {\r\n  #article-component .content-wrap { flex-direction: column-reverse; width: 696px; margin-left: auto; margin-right: auto; }\r\n}\r\n@media screen and (max-width: 767px) {\r\n  #article-component .content-wrap { width: 100%; }\r\n  #article-component .content-wrap .copy-wrap { padding: 66px; }\r\n}\r\n@media screen and (max-width: 599px) {\r\n  #article-component .content-wrap .copy-wrap { padding: 33px; }\r\n}\r\n<\/style>\r\n<div class=\"row\" id=\"article-component\">\r\n<div class=\"container\">\r\n  <div class=\"row\">\r\n    <div class=\"col-xxxs-12 col-md-12 col-lg-12 col-xl-12\">\r\n      <div class=\"content-wrap\">\r\n        <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.americanconference.com\/glp-1-law-policy\/wp-content\/uploads\/sites\/2215\/2026\/03\/140L25_LinkedIn_General_1200x1200.png\" alt=\"article\" width=\"672\" height=\"672\">\r\n        <div class=\"copy-wrap\">\r\n          <h5>Join Our Companion Event<\/h5>\r\n          <h2>GLP-1 Law &#038; Policy<\/h2>\r\n          <p><strong>June 4, 2026 &bull; 3 Times Square, New York, NY<\/strong><br>\r\n          Join industry leaders in-person in New York City for this timely event that will cover everything from advertising to mass torts to peptides.<\/p>\r\n          <a href=\"https:\/\/www.americanconference.com\/glp-1-law-policy\/\">Learn More<\/a>\r\n        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n  <\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- #14 ARTICLE END -->\r\n\r\n\r\n<!-- FOLD END -->\r\n<\/div>\r\n<\/div>","protected":false},"excerpt":{"rendered":"Latest News &#038; Updates View the Agenda See the sessions shaping this year\u2019s discussion. View Agenda Who&#8217;s Attending? See the companies already confirmed to attend. VIEW ATTENDEES Stay Ahead in a Defining Year for Biosimilars and Biologics Join ACI\u2019s Biosimilars &#038; Innovator Biologics Summit in New York and connect with industry leaders navigating the biggest&hellip;","protected":false},"author":14692,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-event-overview.php","meta":{"footnotes":""},"class_list":["post-1547","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Overview | Biosimilars &amp; Innovator Biologics<\/title>\n<meta name=\"description\" content=\"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.americanconference.com\/biosimilars\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biosimilars &amp; Innovator Biologics\" \/>\n<meta property=\"og:description\" content=\"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.americanconference.com\/biosimilars\/\" \/>\n<meta property=\"og:site_name\" content=\"Biosimilars &amp; Innovator Biologics\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T16:13:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2026\/01\/658L26_linkedin_general_1200x1200.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2023\/03\/658L23_twitter.png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/\",\"url\":\"https:\/\/www.americanconference.com\/biosimilars\/\",\"name\":\"Overview | Biosimilars &amp; Innovator Biologics\",\"isPartOf\":{\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg\",\"datePublished\":\"2023-02-23T17:38:35+00:00\",\"dateModified\":\"2026-05-22T16:13:11+00:00\",\"description\":\"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.americanconference.com\/biosimilars\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage\",\"url\":\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg\",\"contentUrl\":\"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg\",\"width\":672,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.americanconference.com\/biosimilars\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overview\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.americanconference.com\/biosimilars\/#website\",\"url\":\"https:\/\/www.americanconference.com\/biosimilars\/\",\"name\":\"Biosimilars &amp; Innovator Biologics\",\"description\":\"Template used to create new conference sites\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.americanconference.com\/biosimilars\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overview | Biosimilars &amp; Innovator Biologics","description":"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.americanconference.com\/biosimilars\/","og_locale":"en_US","og_type":"article","og_title":"Biosimilars &amp; Innovator Biologics","og_description":"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.","og_url":"https:\/\/www.americanconference.com\/biosimilars\/","og_site_name":"Biosimilars &amp; Innovator Biologics","article_modified_time":"2026-05-22T16:13:11+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2026\/01\/658L26_linkedin_general_1200x1200.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2023\/03\/658L23_twitter.png","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.americanconference.com\/biosimilars\/","url":"https:\/\/www.americanconference.com\/biosimilars\/","name":"Overview | Biosimilars &amp; Innovator Biologics","isPartOf":{"@id":"https:\/\/www.americanconference.com\/biosimilars\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage"},"image":{"@id":"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage"},"thumbnailUrl":"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg","datePublished":"2023-02-23T17:38:35+00:00","dateModified":"2026-05-22T16:13:11+00:00","description":"Explore legal, regulatory, and commercial strategies for biosimilars and biologics as the next decade of BPCIA litigation, IPRs, and market growth unfolds.","breadcrumb":{"@id":"https:\/\/www.americanconference.com\/biosimilars\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.americanconference.com\/biosimilars\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.americanconference.com\/biosimilars\/#primaryimage","url":"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg","contentUrl":"https:\/\/www.americanconference.com\/biosimilars\/wp-content\/uploads\/sites\/2011\/2025\/09\/658L26-BOS-Overview-01.jpg","width":672,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/www.americanconference.com\/biosimilars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.americanconference.com\/biosimilars\/"},{"@type":"ListItem","position":2,"name":"Overview"}]},{"@type":"WebSite","@id":"https:\/\/www.americanconference.com\/biosimilars\/#website","url":"https:\/\/www.americanconference.com\/biosimilars\/","name":"Biosimilars &amp; Innovator Biologics","description":"Template used to create new conference sites","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.americanconference.com\/biosimilars\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/pages\/1547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/users\/14692"}],"replies":[{"embeddable":true,"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/comments?post=1547"}],"version-history":[{"count":16,"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/pages\/1547\/revisions"}],"predecessor-version":[{"id":3215,"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/pages\/1547\/revisions\/3215"}],"wp:attachment":[{"href":"https:\/\/www.americanconference.com\/biosimilars\/wp-json\/wp\/v2\/media?parent=1547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}